- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05192083
A Pilot Trial of a Smartphone-based Self-management Support Program for COPD Patients
A Pilot Trial of a Smartphone-based Self-management Support Program for Patients With Chronic Obstructive Pulmonary Disease
COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.
The current proposal is to evaluate the feasibility and acceptability of a pilot trial of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Chronic obstructive pulmonary disease (COPD) is the number 3 killer globally by 2020. COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.
Current policy for the prevention and management of long-term conditions focuses on efforts to prevent the onset or slow progression of disease early in the disease trajectory. This prevention paradigm has only recently been adopted for COPD. Systematic reviews have shown self-management support for patients with COPD is effective in improving health-related quality of life and in reducing hospital admissions, but the evidence comes largely from patients with moderate or severe disease and is predominantly recruited from secondary care. Simple and systematic strategies are needed to improve out-of-hospital support and management for people living with COPD.
An instant messaging smartphone app, which allows texts, audio, pictures and video messages to be shared in chat groups, is already available to and is the most popular in the Hong Kong general public. Mobile instant messaging can be conducted through a daily use device to increase access and efficacy, which has been suggested as a feasible approach to delivering an intervention with positive effects on health behaviours and outcomes. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change in diabetes self-management, weight loss, physical activity, smoking cessation and medication adherence with quantitative and qualitative evidence. However, the investigator has not found messaging intervention that was applied in people with COPD, except an ongoing study of using instant text message support for patients with chronic respiratory and cardiovascular diseases.
Hence, the current intervention program is to evaluate the feasibility and acceptability of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Asa Choi, MA
- Numéro de téléphone: 852-3917-6563
- E-mail: asachoi@hku.hk
Sauvegarde des contacts de l'étude
- Nom: Agnes YK Lai, PhD
- Numéro de téléphone: 852-3917-6328
- E-mail: agneslai@hku.hk
Lieux d'étude
-
-
-
Hong Kong, Hong Kong, 852
- Recrutement
- Queen Mary Hospital
-
Contact:
- David Lam, PhD
- Numéro de téléphone: 2255-4455
- E-mail: slnga@hku.hk
-
Contact:
- Agnes Lai, PhD
- Numéro de téléphone: 93176779
- E-mail: agneslai@hku.hk
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion criteria
- Aged 18 years and above
- Diagnosis with COPD
- General condition stable
- Able to speak and read Chinese
- Able to complete the self-administered questionnaire
- Able to use instant messages such as WhatsApp or WeChat
- Mental, cognitive and physically fit for joining the trial as determined by the clinician or responsible investigator
- Signed informed consent
Exclusion criteria
- Skeletal fragility
- Serious active infection
- Inability to walk
- Severe respiratory insufficiency
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Intervention group
The intervention group will receive a smartphone-based self-management support programme, including a 30-min face-to-face or online session at baseline, 3 phone calls (week 2, week 4 and week 6) and 2-month mobile messages in addition to usual care.
|
A smartphone-based self-management support programme includes a 30-min face-to-face or online session at baseline, 3 phone calls and 2-month mobile messages
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change from baseline COPD-related quality of life
Délai: Baseline, Week 8
|
COPD symptoms and impacts and activity level were measured by an 8-item COPD Assessment Test.
Total scores range from 0 to 40, with higher scores denoting a more severe impact of COPD on a patient's life.
|
Baseline, Week 8
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change from baseline patient activation
Délai: Baseline, Week 8
|
Knowledge, skills and confidence in self-management were measured by a 13-item Patient Activation Measure Scale.
The total score ranges from 0 (no activation) to 100 (high activation), with higher scores denoting the better patient activation.
|
Baseline, Week 8
|
Change from baseline self-efficacy for self-management
Délai: Baseline, Week 8
|
Confidence and perceived ability of self-care were measured by a 6-item Stanford self-efficacy scale.
The score for each item ranges from 1 (not at all confident) to 10 (totally confident).
The total score of the scale is the mean of the six items, with higher number indicates higher self-efficacy.
|
Baseline, Week 8
|
Change from baseline acceptance of illness
Délai: Baseline, Week 8
|
Acceptance of illness measured by a 8-item acceptance of illness scale.
Each item ranges from 1 to 5. The total score of the scale is between 8 and 40, with low score showing a lack of adjustment to the disease, no acceptance of the condition, and mental discomfort, while high score indicating good disease acceptance.
|
Baseline, Week 8
|
Change from baseline medication adherence
Délai: Baseline, Week 8
|
Medication adherence measured by a 4-item Morisky Medication-Taking Adherence Scale.
The scale consists of four items with a scoring scheme of "Yes" = 0 and "No" = 1.
All items are summed to give a range of scores from 0 to 4, with higher score indicating a low level of medication adherence.
|
Baseline, Week 8
|
Change from baseline physical activity level
Délai: Baseline, Week 8
|
Physical activity measured by a 7-item International Physical Activity Questionnaire-short form.
Number of days and duration (in hours and minutes) engaging in vigorous activities, moderate activities, and walking in past 7 days will be collected.
Duration (in hours and minutes) of sitting time on week days and weekends will be collected.
|
Baseline, Week 8
|
Change from dyspnea severity
Délai: Baseline, week 8
|
Dyspnea severity measured by a 1-item MRC dyspnea scale.
The scale consists of five statements about perceived breathlessness: grade 1, "I only get breathless with strenuous exercise"; grade 2, "I get short of breath when hurrying on the level or up a slight hill"; grade 3, "I walk slower than people of the same age on the level because of breathlessness or have to stop for breath when walking at my own pace on the level"; grade 4, "I stop for breath after walking 100 yards or after a few minutes on the level"; grade 5, " I am too breathless to leave the house".
Patients selected the grade that applied to them.
|
Baseline, week 8
|
Change from baseline Health status
Délai: Baseline, Week 8
|
Health status measured by a 5-item EuroQol 5-Dimension questionnaire.
The scale comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension was scored by five levels, with 1 representing no problem and 5 representing extreme problem.
|
Baseline, Week 8
|
Change from anxiety and depressive symptoms
Délai: Baseline, Week 8
|
Anxiety and depressive symptoms measured by a 14-item Hospital Anxiety and Depression Scale.
Each item ranges from 0-3.
The total scores of both Anxiety and Depression subscales range from 0-21, with higher scores indicating higher level of anxiety and depression respectively.
|
Baseline, Week 8
|
Change in baseline social support
Délai: Baseline, Week 8
|
Social support measured by a 6-item Multidimensional Scale of Perceived Social Support.
Each item ranges from 1 (very strongly disagree) to 7 (very strongly agree).
The total score is the sum across all items divided by 6, with higher score indicating more social support.
|
Baseline, Week 8
|
Change in from baseline sleep quality
Délai: Baseline, Week 8
|
Sleep quality measured by a 7-item Insomnia Severity Index.
The total score range from 0 (absence of insomnia) to 28 (severe insomnia).
|
Baseline, Week 8
|
Change in baseline grip strength
Délai: Baseline, Week 8
|
Grip strength of both hands measured by dynamometer
|
Baseline, Week 8
|
Change in baseline balance
Délai: Baseline, Week 8
|
Balance assessed by a single-leg stance test.
|
Baseline, Week 8
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Publications générales
- Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. 2015 Mar 18;36:393-415. doi: 10.1146/annurev-publhealth-031914-122855.
- Buttery SC, Zysman M, Vikjord SAA, Hopkinson NS, Jenkins C, Vanfleteren LEGW. Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity. Respirology. 2021 May;26(5):419-441. doi: 10.1111/resp.14032. Epub 2021 Mar 9.
- Jolly K, Sidhu MS, Hewitt CA, Coventry PA, Daley A, Jordan R, Heneghan C, Singh S, Ives N, Adab P, Jowett S, Varghese J, Nunan D, Ahmed K, Dowson L, Fitzmaurice D. Self management of patients with mild COPD in primary care: randomised controlled trial. BMJ. 2018 Jun 13;361:k2241. doi: 10.1136/bmj.k2241.
- Redfern J, Hyun K, Singleton A, Hafiz N, Raeside R, Spencer L, Carr B, Caterson I, Cullen J, Ferry C, Santo K, Hayes A, Leung RWM, Raadsma S, Swinbourne J, Cho JG, King M, Roberts M, Kok C, Jenkins C, Chow C. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial. BMJ Open. 2019 Mar 1;9(3):e023863. doi: 10.1136/bmjopen-2018-023863.
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- UW21-532-2
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Self-management and Support
-
hearX GroupUniversity of PretoriaComplété
-
Dartmouth-Hitchcock Medical CenterUnited States Department of DefenseRecrutementLésions cérébrales, traumatiques | Épilepsie, TraumatiqueÉtats-Unis